Australian Clinical Labs
ACL.AX
#7129
Rank
NZ$0.66 B
Marketcap
$3.35
Share price
2.64%
Change (1 day)
24.45%
Change (1 year)

EPS for Australian Clinical Labs (ACL.AX)

EPS in 2023: $0.20

According to Australian Clinical Labs's latest financial reports the company's current EPS (TTM) is $0.20. In 2023 the company made an earnings per share (EPS) of $0.20 a decrease over its 2022 EPS that were of $1.03.

EPS history for Australian Clinical Labs from 2021 to 2023

Annual EPS

Year EPS Change
2023$0.20-80.55%
2022$1.03104.3%
2021$0.50